Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yishen Tiaojing Pill
- Development stage
- Preclinical
- Lead developer
- Jingzhou Traditional Chinese Medicine Hospital
- Administration
- Oral
01
Overview
Yishen Tiaojing Pill is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of premature ovarian insufficiency (POI). Based on TCM principles of tonifying the kidney and regulating menstruation, the pill is intended to improve ovarian function and restore hormonal balance in patients experiencing early loss of ovarian activity. It is currently being evaluated in clinical trials sponsored by the Jingzhou Traditional Chinese Medicine Hospital to assess its efficacy and safety in managing POI, likely by modulating the hypothalamus-pituitary-ovarian (HPO) axis.
- Other names
- Yishen Tiaojing Wan
Beyond the preview
Go deeper on Yishen Tiaojing Pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yishen Tiaojing Pill.